Compounds are provided that are amide analogs of SR141716Ahaving unique CB1 receptor selectivity and providing WIN sparingbinding characteristics, pharmaceutical compositions containing thecompounds and their use in a method of treatment of CB1 receptorrelated disorders, such as obesity, schizophrenia, memorydysfunction and marijuana abuse.
Compounds having unique CB1 receptor binding selectivity and methods for their production and use
Thomas, B., Seltzman, H., & Francisco, MY. (2004). IPC No. U.S. Compounds having unique CB1 receptor binding selectivity and methods for their production and use. (Patent No. 6825209).
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.